Equities researchers at StockNews.com began coverage on shares of Mannatech (NASDAQ:MTEX – Get Free Report) in a research report issued on Monday. The firm set a “buy” rating on the stock.
Mannatech Stock Performance
NASDAQ MTEX opened at $7.50 on Monday. The firm has a 50-day moving average of $7.37 and a 200-day moving average of $7.71. The company has a debt-to-equity ratio of 0.54, a quick ratio of 0.62 and a current ratio of 1.17. The stock has a market cap of $14.14 million, a PE ratio of -8.43 and a beta of 1.17. Mannatech has a 52-week low of $6.75 and a 52-week high of $11.80.
Mannatech (NASDAQ:MTEX – Get Free Report) last issued its quarterly earnings data on Tuesday, August 13th. The company reported ($0.33) earnings per share for the quarter. Mannatech had a negative return on equity of 11.87% and a negative net margin of 0.97%. The business had revenue of $27.74 million during the quarter.
Insiders Place Their Bets
Mannatech Company Profile
Mannatech, Incorporated operates as a health and wellness company in the Americas, Europe, the Middle East, Africa, and the Asia-Pacific. The company develops, markets, and sells nutritional supplements; topical and skin care, and anti-aging products; and weight-management and fitness products. It primarily sells its products directly, as well as through e-commerce and network marketing channels.
Further Reading
- Five stocks we like better than Mannatech
- Airline Stocks – Top Airline Stocks to Buy Now
- Biohaven Stock Soars on Drug Trial Results: Time to Jump In?
- Using the MarketBeat Dividend Yield Calculator
- Is AMD a Legitimate Threat to NVIDIA? What Investors Should Watch
- 3 Home Improvement Stocks that Can Upgrade Your Portfolio
- Novo Nordisk’s Setback Won’t Last: A Game-Changing Drug Emerges
Receive News & Ratings for Mannatech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mannatech and related companies with MarketBeat.com's FREE daily email newsletter.